25

Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 2: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 3: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 4: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 5: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 6: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 7: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 8: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 9: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 10: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 11: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 12: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 13: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 14: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 15: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 16: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 17: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 18: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 19: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 20: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 21: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 22: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 23: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 24: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions
Page 25: Reproxalap Phase 2b Dry Eye Disease Results · Phase 2b Dry Eye Disease Clinical Trial Visit 2 Day 1 Visit 3 week 2 Visit 4 week 4 Evaluate efficacy of reproxalap ophthalmic solutions